Search results for " miRNA"

showing 10 items of 71 documents

Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm

2021

Simple Summary For the first time, neuronal features are described in blastic plasmacytoid dendritic cell neoplasm (BPDCN) by a complex array of molecular techniques, including microRNA and gene expression profiling, RNA and Chromatin immunoprecipitation sequencing, and immunohistochemistry. The discovery of unexpected neural features in BPDCN may change our vision of this disease, leading to the designing of a new BPDCN cell model and to re-thinking the relations occurring between BPDCN and nervous system. The observed findings contribute to explaining the extreme tumor aggressiveness and also to propose novel therapeutic targets. In view of this, the identification, in this work of new po…

Cancer ResearchNeurogenesisNeoplasms. Tumors. Oncology. Including cancer and carcinogensMicroRNA Expression ProfilesequencingBiologySettore MED/08 - Anatomia PatologicaBPDCN MiRNA Network Neurogenesis SequencingBPDCNArticleChromatinGene expression profilingBPDCN; MiRNA; Network; Neurogenesis; SequencingneurogenesisOncologyDownregulation and upregulationmicroRNAnetworkCancer researchImmunohistochemistrySettore MED/05 - Patologia ClinicaNeurogenesiRC254-282ProgenitormiRNACancers
researchProduct

Key lncRNAs involved in ischemic strokes

2022

NA

Cancer Researchmedicine.medical_specialtyIschemic strokesBiologymedicine.diseaseBrain Ischemiaischemic stroke lncRNAs miRNAs RNA transcripts stroke Humans Brain Ischemia Ischemic Stroke RNA Long NoncodingInternal medicineIschemic strokeGeneticsKey (cryptography)medicineCardiologyHumansRNA Long NoncodingStrokeIschemic StrokeEpigenomics
researchProduct

Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs

2015

Nucleic acid based drugs (NADBs) are short DNA/RNA molecules that include among others, antisense oligonucleotides, aptamers, small interfering RNAs and micro-interfering RNAs. Despite the different mechanisms of actions, NABDs have the ability to combat the effects of pathological gene expression in many experimental systems. Thus, nowadays, NABDs are considered to have a great therapeutic potential, possibly superior to that of available drugs. Unfortunately, however, the lack of effective delivery systems limits the practical use of NABDs. Due to their hydrophilic nature, NABDs cannot efficiently cross cellular membrane; in addition, they are subjected to fast degradation by cellular and…

Cellular membranePolymersAntisense oligonucleotides aptamers carbon nanotubes exososomes liposomes miRNA polymers siRNAAptamerClinical BiochemistryNanotechnologyAnimals; Humans; Lipids; Nanoparticles; Nanotubes Carbon; Nucleic Acids; Polymers; Drug Delivery SystemsBiologyNanoparticleDrug Delivery SystemsNucleic AcidsAnimalsHumansAvailable drugsPolymerPharmacologyNanotubesNucleic AcidAnimalNanotubes CarbonCarbon chemistryRNALipidLipidsCarbonSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAntisense oligonucleotidesNucleic acidNanoparticlesHuman
researchProduct

Circulating miRNA expression analysis reveals new potential biomarkers for human cutaneous melanoma staging.

2019

Circulating mirnasSkin Neoplasmsbusiness.industrySequence Analysis RNADermatologyInfectious DiseasesPotential biomarkersExpression analysisCutaneous melanomaCancer researchBiomarkers TumorMedicineHumansCirculating MicroRNAbusinessMelanomaNeoplasm StagingJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct

Editorial: The Role of the Muscle Secretome in Health and Disease

2020

myokines, exercise, muscle-derived secreted factors, circulating miRNA, extracellular vesicles

Circulating mirnasexerciselcsh:QP1-981Physiologybusiness.industrymyokinesmuscle-derived secreted factors.DiseaseBioinformaticsExtracellular vesicleslcsh:Physiologycirculating miRNAPhysiology (medical)MyokineMedicineextracellular vesiclebusinessextracellular vesiclesmuscle-derived secreted factorsFrontiers in Physiology
researchProduct

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women

2014

INTRODUCTION: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set.METHODS: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR).RESULTS: Numbers of specific miRNAs detected in the samples ranged fro…

Circulating mirnaslcsh:MedicineEstrogen receptorBreast NeoplasmsBioinformaticsBiochemistryBreast cancerSurgical oncologymicroRNABreast TumorsBreast CancermedicineMedicine and Health SciencesBiomarkers TumorHumansPostoperative PeriodStage (cooking)lcsh:Scienceskin and connective tissue diseasesAgedNeoplasm StagingAged 80 and overMultidisciplinarybusiness.industrylcsh:RCarcinoma Ductal BreastCancerBiology and Life SciencesCancers and NeoplasmsMiddle Agedmedicine.diseasePostmenopauseCirculating MicroRNAMicroRNAsOncologyReceptors Estrogenlcsh:QFemalebusinessBiomarkersResearch ArticlePLoS ONE
researchProduct

The Potential Role of miRNAs in Cognitive Frailty.

2021

Frailty is an aging related condition, which has been defined as a state of enhanced vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Cognitive impairment is also frequent in older people, often accompanying frailty. Age is the main independent risk factor for both frailty and cognitive impairment, and compelling evidence suggests that similar age-associated mechanisms could underlie both clinical conditions. Accordingly, it has been suggested that frailty and cognitive impairment share common pathways, and some authors proposed “cognitive frailty” as a single complex phenotype. Nevertheless, so far, no clear common underlying pathways have been discove…

Cognitive frailtyAgingbiomarkers cognitive frailty cognitive impairment frailty MCI (mild cognitive impairment) miRNA–microRNACognitive NeuroscienceVulnerabilitycognitive frailtyNeurosciences. Biological psychiatry. NeuropsychiatryReviewfrailtyMCI (mild cognitive impairment)MCI (mild cognitive impairment); biomarkers; cognitive frailty; cognitive impairment; frailty; miRNA–microRNAmicroRNAMedicinePathologicalcognitive impairmentbusiness.industryStressorbiomarkers; cognitive frailty; cognitive impairment; frailty; MCI (mild cognitive impairment); miRNA–microRNAbiomarkersCognitionPhenotypemiRNA–microRNAPotential biomarkersbiomarkerbusinessNeuroscienceRC321-571NeuroscienceFrontiers in aging neuroscience
researchProduct

The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg?

2013

Esophageal adenocarcinoma originates from columnar metaplastic epithelium of the distal esophagus. Various steps for this carcinogenetic process are known. Before the onset of high-grade dysplasia and adenocarcinoma, endoscopic surveillance is possible. However, because of the high cost of long-term surveillance, predictive factors for cancer are being evaluated to identify subjects with metaplasia who have a higher risk of developing malignancy. Molecular changes seem suitable for this purpose, but could require a high resource expenditure. While trying to identify the best predictive factors for cancer risk, molecular changes and differences in miRNA expression profile between the various…

DysplasiaPathologymedicine.medical_specialtyEsophageal NeoplasmsSettore MED/06 - Oncologia MedicaCarcinogenesisSettore MED/08 - Anatomia PatologicaAdenocarcinomaMalignancymedicine.disease_causeBarrett EsophagusMetaplasiamicroRNAmedicineHumansMetaplasiabusiness.industryEndoscopic surveillanceCancerBarrett's esophaguBarrett's esophagus; Metaplasia; Dysplasia; Adenocarcinoma; Endoscopic surveillance; miRNAsHematologymedicine.diseaseSettore MED/18 - Chirurgia GeneraleMicroRNAsOncologyDysplasiaBarrett's esophagusmiRNAsCancer researchDisease ProgressionAdenocarcinomamedicine.symptombusinessCarcinogenesisBiomarkersCritical reviews in oncology/hematology
researchProduct

Non-coding RNAs and Coronary Artery Disease

2020

Coronary artery disease (CAD) is the leading death cause worldwide. Non-coding RNA (ncRNA) are key regulators of genetic expression and thus can affect directly or indirectly the development and progression of different diseases. ncRNA can be classified in several types depending on the length or structure, as long non-coding RNA (lncRNA), microRNA (miRNA) and circularRNA (circRNA), among others. These types of RNA are present within cells or in circulation, and for this reason they have been used as biomarkers of different diseases, therefore revolutionizing precision medicine. Recent research studied the capability of circulating ncRNA to inform about CAD presence and predict the outcome …

Enfermedad cardiovascularRNABiomarkerDiseaseComputational biologyGenética humanaBiologyNon-coding RNAPrecision medicinemedicine.diseaseARNCoronary artery disease (CAD)Coronary artery disease03 medical and health scienceslncRNA0302 clinical medicineBiomarker; Coronary artery disease (CAD); circRNA; lncRNA; miRNAGene expressionmicroRNAmedicineBiomarker (medicine)Cardiopatía coronariacircRNA030212 general & internal medicinemiRNA
researchProduct

Epigenetic biomarkers: A new perspective in laboratory diagnostics.

2012

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare…

EpigenomicsClinical BiochemistryBiologyBiochemistryEpigenesis GeneticHistonesmicroRNACancer; DNA methylation; Histone; MiRNAs; Rare disease;HumansEpigeneticsPathology MolecularEpigenesisEpigenomicsCancerGeneticsEpigenetic biomarkersBiochemistry (medical)Nuclear organizationGeneral MedicineSequence Analysis DNADNA MethylationHistoneMicroRNAsHistoneDNA methylationbiology.proteinMiRNAsRare diseaseProtein Processing Post-TranslationalBiomarkersClinica chimica acta; international journal of clinical chemistry
researchProduct